MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/1744-9987.70201

Медицинская библиотека · Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026

Cell Damage-Like Proteomic Signatures Distinguish Cell-Free and Concentrated Ascites Reinfusion Therapy (CART) Membranes in Malignant Ascites: A Mechanistic Study.

Nojima Masaki, Murayama Goh, Inoue Moeko, Urita Takuya, Ohtsuki Sumio, Hirayama Takashi, Uchiyama Akira, Yamaji Yu, Hagiwara Yukitomo, Saito Takumi, Kuga Taiga, Miyashita Tomoko, Kusaoi Makio, Terao Yasuhisa, Itakura Atsuo, Ikejima Kenichi, Tamura Naoto, Yamaji Ken

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Cell-free and concentrated ascites reinfusion therapy (CART) alleviates the symptoms of malignant ascites but may trigger inflammation. We investigated why AHF-MO filter (A-A)-processed concentrates showed weaker bioactivity than EC20W filter (A-E)-processed concentrates.

METHODS

Ascites from three patients with ovarian cancer were processed into untreated ascites (UA), A-A, or A-E. Whole ascites, extracellular vesicles (EVs), and EV-depleted supernatants were injected intraperitoneally into mice. Serum cytokines were measured, and label-free proteomics was used to identify inflammatory pathways.

RESULTS

A-E induced the strongest proinflammatory and Th17/type I interferon responses compared to UA. A-A produced intermediate activation. EV-depleted A-E supernatants remained highly bioactive. A-E was enriched in proteins associated with cellular damage pathways and proinflammatory signaling. A-A exhibited attenuated changes and preserved regulatory proteins.

CONCLUSION

A-A yields a more balanced inflammatory and proteomic profile than A-E. Our findings provide a preliminary mechanistic rationale for its use in CART and offer targets for membrane optimization.

Для цитирования: Nojima Masaki, Murayama Goh, Inoue Moeko, Urita Takuya, Ohtsuki Sumio, Hirayama Takashi, Uchiyama Akira, Yamaji Yu, Hagiwara Yukitomo, Saito Takumi, Kuga Taiga, Miyashita Tomoko, Kusaoi Makio, Terao Yasuhisa, Itakura Atsuo, Ikejima Kenichi, Tamura Naoto, Yamaji Ken. Cell Damage-Like Proteomic Signatures Distinguish Cell-Free and Concentrated Ascites Reinfusion Therapy (CART) Membranes in Malignant Ascites: A Mechanistic Study.. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2026. DOI: 10.1002/1744-9987.70201.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.